- Home
- EVAX vs EDTK Comparison
EVAX vs EDTK Comparison
Compare EVAX & EDTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- EDTK
- Stock Information
- Founded
- EVAX 2008
- EDTK 2013
- Country
- EVAX Denmark
- EDTK China
- Employees
- EVAX N/A
- EDTK N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- EDTK Other Consumer Services
- Sector
- EVAX Health Care
- EDTK Real Estate
- Exchange
- EVAX Nasdaq
- EDTK Nasdaq
- Market Cap
- EVAX 16.3M
- EDTK 16.2M
- IPO Year
- EVAX 2021
- EDTK 2020
- Fundamental
- Price
- EVAX $1.69
- EDTK $1.01
- Analyst Decision
- EVAX Strong Buy
- EDTK
- Analyst Count
- EVAX 2
- EDTK 0
- Target Price
- EVAX $10.00
- EDTK N/A
- AVG Volume (30 Days)
- EVAX 65.8K
- EDTK 7.6K
- Earning Date
- EVAX 05-27-2025
- EDTK 04-11-2025
- Dividend Yield
- EVAX N/A
- EDTK N/A
- EPS Growth
- EVAX N/A
- EDTK N/A
- EPS
- EVAX N/A
- EDTK N/A
- Revenue
- EVAX $3,344,000.00
- EDTK $624,365.00
- Revenue This Year
- EVAX $102.45
- EDTK N/A
- Revenue Next Year
- EVAX $200.44
- EDTK N/A
- P/E Ratio
- EVAX N/A
- EDTK N/A
- Revenue Growth
- EVAX 4480.82
- EDTK N/A
- 52 Week Low
- EVAX $1.61
- EDTK $0.84
- 52 Week High
- EVAX $22.05
- EDTK $1.27
- Technical
- Relative Strength Index (RSI)
- EVAX 36.47
- EDTK 45.53
- Support Level
- EVAX $1.67
- EDTK $0.99
- Resistance Level
- EVAX $1.97
- EDTK $1.03
- Average True Range (ATR)
- EVAX 0.12
- EDTK 0.04
- MACD
- EVAX 0.04
- EDTK -0.00
- Stochastic Oscillator
- EVAX 22.22
- EDTK 38.32
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About EDTK Skillful Craftsman Education Technology Limited
Skillful Craftsman Education Technology Ltd provides online education and technology services in China. The services comprises of two aspects - Online vocational training and Virtual simulation experimental training. It covers a wide range of subjects, including mechanics, electronics, auto repair and construction. Majority of its revenues are generated from the People's Republic of China.